0 CHECKOUT

PRODUCT FILTERS

REGION

101
97
97
90
90

COUNTRY

88
7
7
7
7

PRICE

6
51
85
262

PUBLISHED

66
72
152
262

PRODUCT TYPE

259
3

Lung Cancer

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

About non-small cell lung cancer therapeutics Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading...

Published:  October 2015
Price:  From

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and...

Published:  March 2015
Price:  From

Global Non Small Cell Lung Cancer Market & Pipeline Insight

Lung cancer has become one of the most prevalent cause of cancer related morbidity and mortality in past several decades across the world. Lungs are a pair of spongy tissues present in the thoracic...

Published:  January 2015
Price:  From

Investigation Report on China's Paclitaxel Market, 2010-2019

When paclitaxel first came into the market, American Food and Drug Administration (FDA) only approved it to be used in the clinical treatment of advanced non-small cell cancer and advanced ovarian cancer....

Published:  June 2015
Price:  From

Investigation Report on China's Capecitabine Market, 2010-2019

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in...

Published:  June 2015
Price:  From

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung...

Published:  February 2015
Price:  From

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

Published:  September 2014
Price:  From

CAS Vinblastine sulfate World Consumption Report

This CAS Vinblastine sulfate World Consumption Report provides data on the net consumption of CAS 143-67-9 - Vinblastine sulfate Substance(s) in each of the countries listed. The Substance(s) covered...

Published:  February 2016
Price: 

CAS Vinblastine World Consumption Report

This CAS Vinblastine World Consumption Report provides data on the net consumption of CAS 865-21-4 - Vinblastine Substance(s) in each of the countries listed. The Substance(s) covered (Vinblastine )...

Published:  February 2016
Price: 

Capecitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Exemestane - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Erlotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Lapatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Gefitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Gemcitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Afatinib - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  February 2016
Price: 

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  February 2016
Price: 

Small-Cell Lung Cancer-API Insights

Summary Small-Cell Lung Cancer-API Insights, 2015 report provides Small-Cell Lung Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report...

Published:  February 2016
Price:  From

Capecitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 
Loading Indicator

Our Clients